Skip to main content
. 2018 Jul 12;5(3):e10200. doi: 10.2196/10200

Table 3.

Symptom score distributions statistics

Sample and time point Skewness (SE) Baseline symptoms, mean (SD) Effect size, Cohen d (95% CI)
Treatment sample (n=1098)

1.27 (1.21 to 1.34)

Pretreatment 0.271 (0.071)a 11.73 (4.83)

Posttreatment 1.359 (0.076)a 5.60 (4.58)
Control sample depression (n=96)

–0.04 (–0.24 to 0.16)

Pretreatment 0.178 (0.109) 10.91 (4.53)

Posttreatment 0.228 (0.109) 11.00 (5.04)

aStatistical significance beyond .05 alpha on a Shapiro-Wilk test for distribution normality; significance is indicative that normal distribution is not supported within the observed sample.